Patents by Inventor Hans Albert Felix Scheuplein

Hans Albert Felix Scheuplein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PD-1 Antibodies
    Publication number: 20230265189
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 24, 2023
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Anti-PD-1 antibodies
    Patent number: 11639385
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: May 2, 2023
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Anti-PD-1 Antibodies
    Publication number: 20200190187
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: December 27, 2019
    Publication date: June 18, 2020
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Anti-PD-1 antibodies
    Patent number: 10544217
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: January 28, 2020
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Anti-PD-1 antibodies
    Patent number: 10239942
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: December 19, 2015
    Date of Patent: March 26, 2019
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Anti-PD-1 Antibodies
    Publication number: 20160319019
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: May 11, 2016
    Publication date: November 3, 2016
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon
  • Anti-PD-1 Antibodies
    Publication number: 20160251436
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: December 19, 2015
    Publication date: September 1, 2016
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon
  • COMBINATION THERAPY WITH IL-12
    Publication number: 20160022777
    Abstract: Pharmaceutical compositions and treatments involving iNKT cell activation are provided.
    Type: Application
    Filed: July 28, 2015
    Publication date: January 28, 2016
    Inventors: Robert Schaub, Hans Albert Felix Scheuplein
  • COMBINATION THERAPY
    Publication number: 20150165021
    Abstract: Pharmaceutical compositions and treatments involving iNKT cell activation are provided.
    Type: Application
    Filed: November 5, 2014
    Publication date: June 18, 2015
    Inventors: Robert Mashal, Hans Albert Felix Scheuplein, Robert Schaub